CC BY-NC 4.0 · Arch Plast Surg 2020; 47(03): 235-241
DOI: 10.5999/aps.2019.01858
Original Article

BellaGel breast implant: 6-Year results of a prospective cohort study

Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
,
Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
,
Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
,
Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
,
Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
,
Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
,
Ara Kim
Department of Plastic and Reconstructive Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
,
Department of Plastic and Reconstructive Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
,
Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
› Author Affiliations

Background This is the first clinical study conducted among Asian women using breast implants manufactured by an Asian company. Four-year data regarding the safety and efficacy of BellaGel breast implants have already been published, and we now report 6-year data.

Methods This study was designed to take place over 10 years. It included 103 patients who underwent breast reconstruction or augmentation using BellaGel breast implants. The rates of implant rupture and capsular contracture were measured and analyzed to evaluate the effectiveness of the breast implant.

Results At patients’ 6-year postoperative visits, the implant rupture and capsular contracture rates were 1.15% and 2.30%, respectively. The implant rupture rate was 3.77% among reconstruction cases and 0% among augmentation cases. The capsular contracture rate was 5.66% among reconstruction cases and 0.83% among augmentation cases.

Conclusions The 6-year data from this planned 10-year study suggest that the BellaGel cohesive silicone gel-filled breast implant is an effective and safe medical device that can be used in breast reconstruction and augmentation.

Hans Biomed provided financial support for this study.




Publication History

Received: 14 December 2019

Accepted: 24 April 2020

Article published online:
22 March 2022

© 2020. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • REFERENCES

  • 1 American Society of Plastic Surgeons (ASPS). 2018 Plastic surgery statistics report [internet]. Arlington Heights, IL: ASPS. c2019 [cited 2020 Feb 15]. Available from: https://www.plasticsurgery.org/news/plastic-surgery-statistics
  • 2 International Society of Aesthetic Plastic Surgery (ISAPS). International survey of aesthetic/cosmetic procedures performed in 2018 [internet]. Hanover, NH: ISAPS. [cited 2020 Feb 15]. Available from: http://www.isaps.org
  • 3 Cronin TD, Gerow FJ. Augmentation mammaplasty: a new “natural feel” prosthesis. In: Broadbent TR. Transactions of the Third International Congress of Plastic Surgery. Amsterdam: Excerpta Medica Foundation; 1964: 41-9
  • 4 Maxwell GP, Baker MR. Augmentation mammaplasty: general considerations. In: Spear SL. Surgery of the breast. 2nd ed. Baltimore: Lippincott Williams & Wilkins; 2006: 1237
  • 5 Danino AM, Basmacioglu P, Saito S. et al. Comparison of the capsular response to the Biocell RTV and Mentor 1600 Siltex breast implant surface texturing: a scanning electron microscopic study. Plast Reconstr Surg 2001; 108: 2047-52
  • 6 Cunningham B. The Mentor study on contour profile gel silicone MemoryGel breast implants. Plast Reconstr Surg 2007; 120 (7 Suppl 1) 33S-39S
  • 7 Cunningham B. The Mentor core study on silicone MemoryGel breast implants. Plast Reconstr Surg 2007; 120 (7 Suppl 1) 19S-32S
  • 8 Bengtson BP, Van Natta BW, Murphy DK. et al. Style 410 highly cohesive silicone breast implant core study results at 3 years. Plast Reconstr Surg 2007; 120 (7 Suppl 1) 40S-48S
  • 9 Stevens WG, Harrington J, Alizadeh K. et al. Five-year follow-up data from the U.S. clinical trial for Sientra’s U.S. Food and Drug Administration-approved Silimed® brand round and shaped implants with high-strength silicone gel. Plast Reconstr Surg 2012; 130: 973-81
  • 10 Handel N, Jensen JA, Black Q. et al. The fate of breast implants: a critical analysis of complications and outcomes. Plast Reconstr Surg 1995; 96: 1521-33
  • 11 Salzberg CA, Ashikari AY, Berry C. et al. Acellular dermal matrix-assisted direct-to-implant breast reconstruction and capsular contracture: a 13-year experience. Plast Reconstr Surg 2016; 138: 329-37
  • 12 Banbury J, Yetman R, Lucas A. et al. Prospective analysis of the outcome of subpectoral breast augmentation: sensory changes, muscle function, and body image. Plast Reconstr Surg 2004; 113: 701-11
  • 13 Han J, Jeong JH, Bang SI. et al. BellaGel breast implant: 4-year results of a prospective cohort study. J Plast Surg Hand Surg 2019; 53: 232-9